Source: NPR Health
Summary
Medicare is providing access to popular obesity medications for a $50 monthly copay, available to eligible beneficiaries. This initiative is a temporary measure set to last until 2027.
Why It Matters
This decision significantly impacts millions of Americans struggling with obesity, making effective treatments more accessible and affordable. By reducing the financial burden, Medicare aims to improve health outcomes and combat obesity-related conditions, which impose high costs on the healthcare system.





